Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ataluren in children 6 months to <2 years with nmDMD
NCT04336826Phase 2Completed
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Dec 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ataluren in Duchenne muscular dystrophy (DMD), sponsored by PTC Therapeutics, Inc.. Started Dec 2021; status: completed.
02
Drugs
ataluren
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT04336826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04336826.